Comparably Awards

Organon Claimed Company

Organon is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed. We are here for her health. read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 361

TOTAL RATINGS: 10294

CEO: Kevin Ali

Kevin Ali Organon CEO Rating

Organon's CEO, Kevin Ali, has 361 employee ratings and a score of 88/100, placing them in the Top 5% of similar size companies on Comparably with 5,001-10,000 Employees and Top 5% of other companies in New York. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that males at Organon rate Kevin Ali higher than females, giving the CEO a score of 89/100.

Last updated months ago.

Where This Score Ranks Organon's CEO Rating

TOP
5%
In the Top 5% of 1808 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 707 Nearby Companies in New York
1st
1st place versus 5 competitors rated on Comparably

Apr

May

Jul

Dec

May

A+88 / 100

Jan

Organon CEO Kevin Ali Bio

Kevin Ali is the CEO and Board member of Organon, a global healthcare company with the vision of creating a better and healthier every day for every woman around the world. Kevin led the formation of Organon in 2021 to address the significant healthcare issues that women face and deliver impactful solutions all over the world.

Kevin has more than three decades of healthcare and commercialization experience from Merck, where he has held a number of leadership roles. Before leading Organon, Kevin was President of Merck’s international business, responsible for commercial markets outside the US which account for 96% of the world’s population and over half of Merck’s pharmaceutical revenues. Under Kevin’s leadership, the business was a significant driver of Merck’s growth. Previously, Kevin served as the President of the emerging markets region where he transformed the performance of many countries for sustained growth and strength. Earlier in his career, Kevin was the Managing Director of Germany and Turkey and also led key therapeutic franchises.

Kevin holds an MBA from Santa Clara University and a Bachelor of Arts from the University of California, Berkeley.

Who Ranks Organon's CEO Rating the Highest?

Department - Design 98/100

Department - Legal 93/100

Department - Business Development 91/100

Who Ranks Organon's CEO Rating the Lowest?

Department - Customer Success 80/100

Department - Engineering 84/100

Department - Marketing 84/100

Organon CEO Kevin Ali At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Organon.

Based on 361 ratings, Kevin Ali ranks right above Roche's CEO, Severin Schwan.

Organon's CEO is highly regarded by the Design department, the Legal department, and the Business Development department. However, the Customer Success department, the Engineering department, and the Marketing department have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.